TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA-Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - BOOK AU - Howlader, N. AU - Noone, A. M. AU - Krapcho, M. AU - Miller, D. AU - Brest, A. AU - Yu, M. PY - 2018 DA - 2018// TI - SEER cancer statistics review, 1975-2016 ID - Howlader2018 ER - TY - JOUR AU - Gul, A. AU - Rini, B. I. PY - 2019 DA - 2019// TI - Adjuvant therapy in renal cell carcinoma JO - Cancer VL - 125 UR - https://doi.org/10.1002/cncr.32144 DO - 10.1002/cncr.32144 ID - Gul2019 ER - TY - STD TI - McKay RR, Bossé D, Choueiri TK. Evolving systemic treatment landscape for patients with advanced renal cell carcinoma. J Clin Oncol. 2018:JCO2018790253. https://doi.org/10.1200/JCO.2018.79.0253. ID - ref4 ER - TY - JOUR AU - Choueiri, T. K. AU - Motzer, R. J. PY - 2017 DA - 2017// TI - Systemic therapy for metastatic renal-cell carcinoma JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMra1601333 DO - 10.1056/NEJMra1601333 ID - Choueiri2017 ER - TY - JOUR AU - Hudes, G. AU - Carducci, M. AU - Tomczak, P. AU - Dutcher, J. AU - Figlin, R. AU - Kapoor, A. PY - 2007 DA - 2007// TI - Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa066838 DO - 10.1056/NEJMoa066838 ID - Hudes2007 ER - TY - JOUR AU - Motzer, R. J. AU - Barrios, C. H. AU - Kim, T. M. AU - Falcon, S. AU - Cosgriff, T. AU - Harker, W. G. PY - 2014 DA - 2014// TI - Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.6911 DO - 10.1200/JCO.2013.54.6911 ID - Motzer2014 ER - TY - JOUR AU - Rini, B. I. AU - Atkins, M. B. PY - 2009 DA - 2009// TI - Resistance to targeted therapy in renal-cell carcinoma JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70240-2 DO - 10.1016/S1470-2045(09)70240-2 ID - Rini2009 ER - TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - McDermott, D. F. AU - George, S. AU - Hammers, H. J. AU - Srinivas, S. PY - 2015 DA - 2015// TI - Nivolumab versus everolimus in advanced renal-cell carcinoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1510665 DO - 10.1056/NEJMoa1510665 ID - Motzer2015 ER - TY - JOUR AU - Rini, B. I. AU - Powles, T. AU - Atkins, M. B. AU - Escudier, B. AU - McDermott, D. F. AU - Suarez, C. PY - 2019 DA - 2019// TI - Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial JO - Lancet VL - 393 UR - https://doi.org/10.1016/S0140-6736(19)30723-8 DO - 10.1016/S0140-6736(19)30723-8 ID - Rini2019 ER - TY - JOUR AU - Rausch, S. AU - Gouttefangeas, C. AU - Hennenlotter, J. AU - Laske, K. AU - Walter, K. AU - Feyerabend, S. PY - 2019 DA - 2019// TI - Results of a phase ½ study in metastatic renal cell carcinoma patients treated with a patient-specific adjuvant multi-peptide vaccine after resection of metastases JO - Eur Urol Focus VL - 5 UR - https://doi.org/10.1016/j.euf.2017.09.009 DO - 10.1016/j.euf.2017.09.009 ID - Rausch2019 ER - TY - JOUR AU - Bezu, L. AU - Kepp, O. AU - Cerrato, G. AU - Pol, J. AU - Fucikova, J. AU - Spisek, R. PY - 2018 DA - 2018// TI - Trial watch: peptide-based vaccines in anticancer therapy JO - Oncoimmunology VL - 7 UR - https://doi.org/10.1080/2162402X.2018.1511506 DO - 10.1080/2162402X.2018.1511506 ID - Bezu2018 ER - TY - JOUR AU - Bilich, T. AU - Nelde, A. AU - Bichmann, L. AU - Roerden, M. AU - Salih, H. R. AU - Kowalewski, D. J. PY - 2019 DA - 2019// TI - The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy JO - Blood VL - 133 UR - https://doi.org/10.1182/blood-2018-07-866830 DO - 10.1182/blood-2018-07-866830 ID - Bilich2019 ER - TY - JOUR AU - Schuster, H. AU - Peper, J. K. AU - Bösmüller, H. -. C. AU - Röhle, K. AU - Backert, L. AU - Bilich, T. PY - 2017 DA - 2017// TI - The immunopeptidomic landscape of ovarian carcinomas JO - Proc Natl Acad Sci U S A VL - 114 UR - https://doi.org/10.1073/pnas.1707658114 DO - 10.1073/pnas.1707658114 ID - Schuster2017 ER - TY - JOUR AU - Löffler, M. W. AU - Mohr, C. AU - Bichmann, L. AU - Freudenmann, L. K. AU - Walzer, M. AU - Schroeder, C. M. PY - 2019 DA - 2019// TI - Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma JO - Genome Med VL - 11 UR - https://doi.org/10.1186/s13073-019-0636-8 DO - 10.1186/s13073-019-0636-8 ID - Löffler2019 ER - TY - JOUR AU - Walz, S. AU - Stickel, J. S. AU - Kowalewski, D. J. AU - Schuster, H. AU - Weisel, K. AU - Backert, L. PY - 2015 DA - 2015// TI - The antigenic landscape of multiple myeloma: mass spectrometry (re) defines targets for T-cell-based immunotherapy JO - Blood VL - 126 UR - https://doi.org/10.1182/blood-2015-04-640532 DO - 10.1182/blood-2015-04-640532 ID - Walz2015 ER - TY - JOUR AU - Kowalewski, D. J. AU - Schuster, H. AU - Backert, L. AU - Berlin, C. AU - Kahn, S. AU - Kanz, L. PY - 2015 DA - 2015// TI - HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL) JO - Proc Natl Acad Sci U S A VL - 112 UR - https://doi.org/10.1073/pnas.1416389112 DO - 10.1073/pnas.1416389112 ID - Kowalewski2015 ER - TY - JOUR AU - Yamada, A. AU - Sasada, T. AU - Noguchi, M. AU - Itoh, K. PY - 2013 DA - 2013// TI - Next-generation peptide vaccines for advanced cancer JO - Cancer Sci VL - 104 UR - https://doi.org/10.1111/cas.12050 DO - 10.1111/cas.12050 ID - Yamada2013 ER - TY - JOUR AU - Marco, M. AU - Peper, J. K. AU - Rammensee, H. G. PY - 2017 DA - 2017// TI - Identification of immunogenic epitopes by MS/MS JO - Cancer J VL - 23 UR - https://doi.org/10.1097/PPO.0000000000000252 DO - 10.1097/PPO.0000000000000252 ID - Marco2017 ER - TY - JOUR AU - Manzo, T. AU - Heslop, H. E. AU - Rooney, C. M. PY - 2015 DA - 2015// TI - Antigen-specific T cell therapies for cancer JO - Hum Mol Genet VL - 24 UR - https://doi.org/10.1093/hmg/ddv270 DO - 10.1093/hmg/ddv270 ID - Manzo2015 ER - TY - JOUR AU - Alexandrov, L. B. AU - Nik-Zainal, S. AU - Wedge, D. C. AU - Aparicio, S. A. J. R. AU - Behjati, S. AU - Biankin, A. V. PY - 2013 DA - 2013// TI - Signatures of mutational processes in human cancer JO - Nature VL - 500 UR - https://doi.org/10.1038/nature12477 DO - 10.1038/nature12477 ID - Alexandrov2013 ER - TY - JOUR AU - Young, M. D. AU - Mitchell, T. J. AU - Vieira Braga, F. A. AU - Tran, M. G. B. AU - Stewart, B. J. AU - Ferdinand, J. R. PY - 2018 DA - 2018// TI - Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors JO - Science VL - 361 UR - https://doi.org/10.1126/science.aat1699 DO - 10.1126/science.aat1699 ID - Young2018 ER - TY - JOUR AU - Chen, F. AU - Zhang, Y. AU - Senbabaoglu, Y. AU - Ciriello, G. AU - Yang, L. AU - Reznik, E. PY - 2016 DA - 2016// TI - Multilevel genomics-based taxonomy of renal cell carcinoma JO - Cell Rep VL - 14 UR - https://doi.org/10.1016/j.celrep.2016.02.024 DO - 10.1016/j.celrep.2016.02.024 ID - Chen2016 ER - TY - JOUR AU - Kowalewski, D. J. AU - Stevanović, S. PY - 2013 DA - 2013// TI - Biochemical large-scale identification of MHC class I ligands JO - Methods Mol Biol VL - 960 UR - https://doi.org/10.1007/978-1-62703-218-6_12 DO - 10.1007/978-1-62703-218-6_12 ID - Kowalewski2013 ER - TY - JOUR AU - Nelde, A. AU - Kowalewski, D. J. AU - Stevanović, S. PY - 1988 DA - 1988// TI - Purification and identification of naturally presented MHC class I and II ligands JO - Methods Mol Biol VL - 2019 UR - https://doi.org/10.1007/978-1-4939-9450-2_10 DO - 10.1007/978-1-4939-9450-2_10 ID - Nelde1988 ER - TY - STD TI - The Universal Protein Resource (UniProt). UniProt Consortium. 2013. https://www.uniprot.org/uniprot/. Accessed 27 Sep 2013. UR - https://www.uniprot.org/uniprot/ ID - ref26 ER - TY - JOUR AU - Käll, L. AU - Canterbury, J. D. AU - Weston, J. AU - Noble, W. S. AU - MacCoss, M. J. PY - 2007 DA - 2007// TI - Semi-supervised learning for peptide identification from shotgun proteomics datasets JO - Nat Methods VL - 4 UR - https://doi.org/10.1038/nmeth1113 DO - 10.1038/nmeth1113 ID - Käll2007 ER - TY - BOOK PY - 2017 DA - 2017// TI - DTU Bioinformatics, Department of Bio and Health Informatics, Lyngby, Denmark ID - ref28 ER - TY - BOOK PY - 2017 DA - 2017// TI - A database of MHC ligands and peptide motifs PB - Institute of Cell Biology, Department of Immunology CY - Tuebingen ID - ref29 ER - TY - STD TI - The Universal Protein Resource (UniProt). UniProt Consortium. 2019. https://www.uniprot.org/mapping/. Accessed 15 May 2019. UR - https://www.uniprot.org/mapping/ ID - ref30 ER - TY - JOUR AU - Winter, S. AU - Fisel, P. AU - Büttner, F. AU - Rausch, S. AU - D’Amico, D. AU - Hennenlotter, J. PY - 2016 DA - 2016// TI - Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep29930 DO - 10.1038/srep29930 ID - Winter2016 ER - TY - JOUR AU - Büttner, F. AU - Winter, S. AU - Rausch, S. AU - Hennenlotter, J. AU - Kruck, S. AU - Stenzl, A. PY - 2018 DA - 2018// TI - Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma JO - BMC Med VL - 16 UR - https://doi.org/10.1186/s12916-018-1088-5 DO - 10.1186/s12916-018-1088-5 ID - Büttner2018 ER - TY - STD TI - NetAffx Analysis Center. Affymetrix, Santa Clara, USA. 2017. https://www.affymetrix.com/analysis/index.affx. Accessed 29 Nov 2017. UR - https://www.affymetrix.com/analysis/index.affx ID - ref33 ER - TY - JOUR AU - Satija, R. AU - Farrell, J. A. AU - Gennert, D. AU - Schier, A. F. AU - Regev, A. PY - 2015 DA - 2015// TI - Spatial reconstruction of single-cell gene expression data JO - Nat Biotechnol VL - 33 UR - https://doi.org/10.1038/nbt.3192 DO - 10.1038/nbt.3192 ID - Satija2015 ER - TY - JOUR AU - Stuart, T. AU - Butler, A. AU - Hoffman, P. AU - Hafemeister, C. AU - Papalexi, E. AU - Mauck, W. M. PY - 2019 DA - 2019// TI - Comprehensive integration of single-cell data JO - Cell VL - 177 UR - https://doi.org/10.1016/j.cell.2019.05.031 DO - 10.1016/j.cell.2019.05.031 ID - Stuart2019 ER - TY - JOUR AU - Lun, A. T. L. AU - McCarthy, D. J. AU - Marioni, J. C. PY - 2016 DA - 2016// TI - A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor JO - F1000Res VL - 5 UR - https://doi.org/10.12688/f1000research.9501.2 DO - 10.12688/f1000research.9501.2 ID - Lun2016 ER - TY - STD TI - Leek JT, Johnson WE, Parker HS, Fertig EJ, Jaffe AE, Storey JD, et al. sva: surrogate variable analysis. R package version 3.28.0. 2018. https://bioconductor.org/packages/release/bioc/html/sva.html. UR - https://bioconductor.org/packages/release/bioc/html/sva.html ID - ref37 ER - TY - BOOK AU - Carlson, M. PY - 2019 DA - 2019// TI - org. Hs.eg.db: Genome wide annotation for Human. R package version 3.8.2 ID - Carlson2019 ER - TY - STD TI - The R Project for Statistical Computing. The R Foundation. 2019. https://www.r-project.org/. Accessed 26 Apr 2019. UR - https://www.r-project.org/ ID - ref39 ER - TY - STD TI - Genomic Data Commons Portal. National Cancer Institute, Bethesda, USA. 2016. https://portal.gdc.cancer.gov/. Accessed 9 Dec 2016. UR - https://portal.gdc.cancer.gov/ ID - ref40 ER - TY - STD TI - The Gene Record Database. National Center for Biotechnology Information (NCBI), Bethesda, USA. 2019. https://www.ncbi.nlm.nih.gov/gene. Accessed 9 Jan 2019. UR - https://www.ncbi.nlm.nih.gov/gene ID - ref41 ER - TY - STD TI - Molecular Signatures Database. Broad Institute, Cambridge, USA. 2017. http://software.broadinstitute.org/gsea/msigdb. Accessed 6 Oct 2017. UR - http://software.broadinstitute.org/gsea/msigdb ID - ref42 ER - TY - JOUR AU - Nath, A. P. AU - Ritchie, S. C. AU - Byars, S. G. AU - Fearnley, L. G. AU - Havulinna, A. S. AU - Joensuu, A. PY - 2017 DA - 2017// TI - An interaction map of circulating metabolites, immune gene networks, and their genetic regulation JO - Genome Biol VL - 18 UR - https://doi.org/10.1186/s13059-017-1279-y DO - 10.1186/s13059-017-1279-y ID - Nath2017 ER - TY - JOUR AU - Hänzelmann, S. AU - Castelo, R. AU - Guinney, J. PY - 2013 DA - 2013// TI - GSVA: gene set variation analysis for microarray and RNA-seq data JO - BMC Bioinformatics VL - 14 UR - https://doi.org/10.1186/1471-2105-14-7 DO - 10.1186/1471-2105-14-7 ID - Hänzelmann2013 ER - TY - STD TI - UCSC Xena browser. University of California, Santa Cruz, USA. 2017. https://tcga.xenahubs.net. Accessed 16 Feb 2017. UR - https://tcga.xenahubs.net ID - ref45 ER - TY - JOUR AU - Kandoth, C. AU - McLellan, M. D. AU - Vandin, F. AU - Ye, K. AU - Niu, B. AU - Lu, C. PY - 2013 DA - 2013// TI - Mutational landscape and significance across 12 major cancer types JO - Nature VL - 502 UR - https://doi.org/10.1038/nature12634 DO - 10.1038/nature12634 ID - Kandoth2013 ER - TY - JOUR AU - Fisel, P. AU - Kruck, S. AU - Winter, S. AU - Bedke, J. AU - Hennenlotter, J. AU - Nies, A. T. PY - 2013 DA - 2013// TI - DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-1180 DO - 10.1158/1078-0432.CCR-13-1180 ID - Fisel2013 ER - TY - JOUR AU - Walter, S. AU - Herrgen, L. AU - Schoor, O. AU - Jung, G. AU - Wernet, D. AU - Bühring, H. -. J. PY - 2003 DA - 2003// TI - Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres JO - J Immunol VL - 171 UR - https://doi.org/10.4049/jimmunol.171.10.4974 DO - 10.4049/jimmunol.171.10.4974 ID - Walter2003 ER - TY - JOUR AU - Rodenko, B. AU - Toebes, M. AU - Hadrup, S. R. AU - Esch, W. J. E. AU - Molenaar, A. M. AU - Schumacher, T. N. M. AU - Ovaa, H. PY - 2006 DA - 2006// TI - Generation of peptide-MHC class I complexes through UV-mediated ligand exchange JO - Nat Protoc VL - 1 UR - https://doi.org/10.1038/nprot.2006.121 DO - 10.1038/nprot.2006.121 ID - Rodenko2006 ER - TY - JOUR AU - Schaeffeler, E. AU - Büttner, F. AU - Reustle, A. AU - Klumpp, V. AU - Winter, S. AU - Rausch, S. PY - 2019 DA - 2019// TI - Metabolic and lipidomic reprogramming in renal cell carcinoma subtypes reflects regions of tumor origin JO - Eur Urol Focus VL - 5 UR - https://doi.org/10.1016/j.euf.2018.01.016 DO - 10.1016/j.euf.2018.01.016 ID - Schaeffeler2019 ER - TY - JOUR AU - Xia, J. AU - Sinelnikov, I. V. AU - Han, B. AU - Wishart, D. S. PY - 2015 DA - 2015// TI - MetaboAnalyst 3.0--making metabolomics more meaningful JO - Nucleic Acids Res VL - 43 UR - https://doi.org/10.1093/nar/gkv380 DO - 10.1093/nar/gkv380 ID - Xia2015 ER - TY - STD TI - RStudio. RStudio, Boston, USA. 2017. https://www.rstudio.com/. Accessed 30 Aug 2017. UR - https://www.rstudio.com/ ID - ref52 ER - TY - BOOK AU - Harrell, F. E. PY - 2019 DA - 2019// TI - Hmisc: Harrell Miscellaneous. R package version 4.2-0 ID - Harrell2019 ER - TY - BOOK AU - Warnes, G. R. AU - Bolker, B. AU - Bonebakker, L. AU - Gentleman, R. AU - Huber, W. AU - Liaw, A. PY - 2019 DA - 2019// TI - gplots: various R programming tools for plotting data. R package version 3.0.1.1 ID - Warnes2019 ER - TY - JOUR AU - Leuthold, P. AU - Schaeffeler, E. AU - Winter, S. AU - Buttner, F. AU - Hofmann, U. AU - Murdter, T. E. PY - 2017 DA - 2017// TI - Comprehensive metabolomic and lipidomic profiling of human kidney tissue: a platform comparison JO - J Proteome Res VL - 16 UR - https://doi.org/10.1021/acs.jproteome.6b00875 DO - 10.1021/acs.jproteome.6b00875 ID - Leuthold2017 ER - TY - STD TI - Metabolite and Chemical Entity Database (METLIN). The Scripps Research Institute, La Jolla, USA. 2017. https://metlin.scripps.edu. Accessed 29 Aug 2017. UR - https://metlin.scripps.edu ID - ref56 ER - TY - BOOK AU - Eklund, A. C. PY - 2016 DA - 2016// TI - beeswarm: the bee swarm plot, an alternative to stripchart. R package version 0.2.3 ID - Eklund2016 ER - TY - STD TI - HLA Ligand Atlas. University of Tuebingen, Tuebingen, Germany. 2019. https://hla-ligand-atlas.org/welcome. UR - https://hla-ligand-atlas.org/welcome ID - ref58 ER - TY - JOUR AU - Chevrier, S. AU - Levine, J. H. AU - Zanotelli, V. R. T. AU - Silina, K. AU - Schulz, D. AU - Bacac, M. PY - 2017 DA - 2017// TI - An immune atlas of clear cell renal cell carcinoma JO - Cell VL - 169 UR - https://doi.org/10.1016/j.cell.2017.04.016 DO - 10.1016/j.cell.2017.04.016 ID - Chevrier2017 ER - TY - JOUR AU - Barbie, D. A. AU - Tamayo, P. AU - Boehm, J. S. AU - Kim, S. Y. AU - Moody, S. E. AU - Dunn, I. F. PY - 2009 DA - 2009// TI - Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 JO - Nature VL - 462 UR - https://doi.org/10.1038/nature08460 DO - 10.1038/nature08460 ID - Barbie2009 ER - TY - JOUR AU - Lindgren, D. AU - Eriksson, P. AU - Krawczyk, K. AU - Nilsson, H. AU - Hansson, J. AU - Veerla, S. PY - 2017 DA - 2017// TI - Cell-type-specific gene programs of the normal human nephron define kidney cancer subtypes JO - Cell Rep VL - 20 UR - https://doi.org/10.1016/j.celrep.2017.07.043 DO - 10.1016/j.celrep.2017.07.043 ID - Lindgren2017 ER - TY - JOUR AU - Buttner, F. AU - Winter, S. AU - Rausch, S. AU - Reustle, A. AU - Kruck, S. AU - Junker, K. PY - 2015 DA - 2015// TI - Survival prediction of clear cell renal cell carcinoma based on gene expression similarity to the proximal tubule of the nephron JO - Eur Urol VL - 68 UR - https://doi.org/10.1016/j.eururo.2015.05.045 DO - 10.1016/j.eururo.2015.05.045 ID - Buttner2015 ER - TY - JOUR PY - 2013 DA - 2013// TI - Comprehensive molecular characterization of clear cell renal cell carcinoma JO - Nature VL - 499 UR - https://doi.org/10.1038/nature12222 DO - 10.1038/nature12222 ID - ref63 ER - TY - JOUR AU - Morris, M. R. AU - Maher, E. R. PY - 2010 DA - 2010// TI - Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics JO - Genome Med VL - 2 UR - https://doi.org/10.1186/gm180 DO - 10.1186/gm180 ID - Morris2010 ER - TY - JOUR AU - Setiadi, A. F. AU - Omilusik, K. AU - David, M. D. AU - Seipp, R. P. AU - Hartikainen, J. AU - Gopaul, R. PY - 2008 DA - 2008// TI - Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-5270 DO - 10.1158/0008-5472.CAN-07-5270 ID - Setiadi2008 ER - TY - JOUR AU - Brocks, D. AU - Schmidt, C. R. AU - Daskalakis, M. AU - Jang, H. S. AU - Shah, N. M. AU - Li, D. PY - 2017 DA - 2017// TI - DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats JO - Nat Genet VL - 49 UR - https://doi.org/10.1038/ng.3889 DO - 10.1038/ng.3889 ID - Brocks2017 ER - TY - JOUR AU - Kwiatkowski, D. J. AU - Choueiri, T. K. AU - Fay, A. P. AU - Rini, B. I. AU - Thorner, A. R. AU - Velasco, G. PY - 2016 DA - 2016// TI - Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-2631 DO - 10.1158/1078-0432.CCR-15-2631 ID - Kwiatkowski2016 ER - TY - JOUR AU - Hakimi, A. A. AU - Ostrovnaya, I. AU - Jacobsen, A. AU - Susztak, K. AU - Coleman, J. A. AU - Russo, P. PY - 2016 DA - 2016// TI - Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma JO - Cancer VL - 122 UR - https://doi.org/10.1002/cncr.29765 DO - 10.1002/cncr.29765 ID - Hakimi2016 ER - TY - JOUR AU - Fiorentino, M. AU - Gruppioni, E. AU - Massari, F. AU - Giunchi, F. AU - Altimari, A. AU - Ciccarese, C. PY - 2017 DA - 2017// TI - Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.12551 DO - 10.18632/oncotarget.12551 ID - Fiorentino2017 ER - TY - JOUR AU - Lennerz, V. AU - Fatho, M. AU - Gentilini, C. AU - Frye, R. A. AU - Lifke, A. AU - Ferel, D. PY - 2005 DA - 2005// TI - The response of autologous T cells to a human melanoma is dominated by mutated neoantigens JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0500090102 DO - 10.1073/pnas.0500090102 ID - Lennerz2005 ER - TY - JOUR AU - Saeterdal, I. AU - Bjørheim, J. AU - Lislerud, K. AU - Gjertsen, M. K. AU - Bukholm, I. K. AU - Olsen, O. C. PY - 2001 DA - 2001// TI - Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.231326898 DO - 10.1073/pnas.231326898 ID - Saeterdal2001 ER - TY - JOUR AU - Huang, J. AU - El-Gamil, M. AU - Dudley, M. E. AU - Li, Y. F. AU - Rosenberg, S. A. AU - Robbins, P. F. PY - 2004 DA - 2004// TI - T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product JO - J Immunol VL - 172 UR - https://doi.org/10.4049/jimmunol.172.10.6057 DO - 10.4049/jimmunol.172.10.6057 ID - Huang2004 ER - TY - JOUR AU - Linnebacher, M. AU - Gebert, J. AU - Rudy, W. AU - Woerner, S. AU - Yuan, Y. P. AU - Bork, P. AU - Knebel Doeberitz, M. PY - 2001 DA - 2001// TI - Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens JO - Int J Cancer VL - 93 UR - https://doi.org/10.1002/ijc.1298 DO - 10.1002/ijc.1298 ID - Linnebacher2001 ER - TY - JOUR AU - Hacohen, N. AU - Fritsch, E. F. AU - Carter, T. A. AU - Lander, E. S. AU - Wu, C. J. PY - 2013 DA - 2013// TI - Getting personal with neoantigen-based therapeutic cancer vaccines JO - Cancer Immunol Res VL - 1 UR - https://doi.org/10.1158/2326-6066.CIR-13-0022 DO - 10.1158/2326-6066.CIR-13-0022 ID - Hacohen2013 ER - TY - JOUR AU - Sampson, J. H. AU - Heimberger, A. B. AU - Archer, G. E. AU - Aldape, K. D. AU - Friedman, A. H. AU - Friedman, H. S. PY - 2010 DA - 2010// TI - Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.28.6963 DO - 10.1200/JCO.2010.28.6963 ID - Sampson2010 ER - TY - JOUR AU - Greiner, J. AU - Ono, Y. AU - Hofmann, S. AU - Schmitt, A. AU - Mehring, E. AU - Götz, M. PY - 2012 DA - 2012// TI - Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2011-11-394395 DO - 10.1182/blood-2011-11-394395 ID - Greiner2012 ER - TY - JOUR AU - Cai, A. AU - Keskin, D. B. AU - DeLuca, D. S. AU - Alonso, A. AU - Zhang, W. AU - Zhang, G. L. PY - 2012 DA - 2012// TI - Mutated BCR-ABL generates immunogenic T-cell epitopes in CML patients JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-1182 DO - 10.1158/1078-0432.CCR-12-1182 ID - Cai2012 ER - TY - STD TI - The Database for Annotation, Visualization and Integrated Discovery (DAVID). Laboratory of Human Retrovirology and Immunoinformatics, Frederick, USA. 2019. Accessed 17 May 2019. ID - ref78 ER - TY - JOUR AU - Huang, D. W. AU - Sherman, B. T. AU - Lempicki, R. A. PY - 2009 DA - 2009// TI - Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists JO - Nucleic Acids Res VL - 37 UR - https://doi.org/10.1093/nar/gkn923 DO - 10.1093/nar/gkn923 ID - Huang2009 ER - TY - JOUR AU - Huang, D. W. AU - Sherman, B. T. AU - Lempicki, R. A. PY - 2009 DA - 2009// TI - Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources JO - Nat Protoc VL - 4 UR - https://doi.org/10.1038/nprot.2008.211 DO - 10.1038/nprot.2008.211 ID - Huang2009 ER - TY - JOUR AU - Mi, H. AU - Muruganujan, A. AU - Ebert, D. AU - Huang, X. AU - Thomas, P. D. PY - 2019 DA - 2019// TI - PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools JO - Nucleic Acids Res VL - 47 UR - https://doi.org/10.1093/nar/gky1038 DO - 10.1093/nar/gky1038 ID - Mi2019 ER - TY - STD TI - Protein Analysis Through Evolutionary Relationships (PANTHER). The Gene Oontology Consortium. 2019. http://pantherdb.org/. Accessed 17 May 2019. UR - http://pantherdb.org/ ID - ref82 ER - TY - JOUR AU - Gatto, F. AU - Nookaew, I. AU - Nielsen, J. PY - 2014 DA - 2014// TI - Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma JO - Proc Natl Acad Sci U S A VL - 111 UR - https://doi.org/10.1073/pnas.1319196111 DO - 10.1073/pnas.1319196111 ID - Gatto2014 ER - TY - JOUR AU - Hakimi, A. A. AU - Reznik, E. AU - Lee, C. H. AU - Creighton, C. J. AU - Brannon, A. R. AU - Luna, A. PY - 2016 DA - 2016// TI - An integrated metabolic atlas of clear cell renal cell carcinoma JO - Cancer Cell VL - 29 UR - https://doi.org/10.1016/j.ccell.2015.12.004 DO - 10.1016/j.ccell.2015.12.004 ID - Hakimi2016 ER - TY - STD TI - Rathmell WK, Rathmell JC, Linehan WM. Metabolic pathways in kidney cancer: current therapies and future directions. J Clin Oncol. 2018:JCO2018792309. https://doi.org/10.1200/JCO.2018.79.2309. ID - ref85 ER - TY - JOUR AU - Gebhard, R. L. AU - Clayman, R. V. AU - Prigge, W. F. AU - Figenshau, R. AU - Staley, N. A. AU - Reesey, C. AU - Bear, A. PY - 1987 DA - 1987// TI - Abnormal cholesterol metabolism in renal clear cell carcinoma JO - J Lipid Res VL - 28 ID - Gebhard1987 ER - TY - JOUR AU - Ackerman, D. AU - Tumanov, S. AU - Qiu, B. AU - Michalopoulou, E. AU - Spata, M. AU - Azzam, A. PY - 2018 DA - 2018// TI - Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation JO - Cell Rep VL - 24 UR - https://doi.org/10.1016/j.celrep.2018.08.015 DO - 10.1016/j.celrep.2018.08.015 ID - Ackerman2018 ER - TY - JOUR AU - Choueiri, T. K. AU - Escudier, B. AU - Powles, T. AU - Mainwaring, P. N. AU - Rini, B. I. AU - Donskov, F. PY - 2015 DA - 2015// TI - Cabozantinib versus everolimus in advanced renal-cell carcinoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1510016 DO - 10.1056/NEJMoa1510016 ID - Choueiri2015 ER - TY - JOUR AU - Rooney, M. S. AU - Shukla, S. A. AU - Wu, C. J. AU - Getz, G. AU - Hacohen, N. PY - 2015 DA - 2015// TI - Molecular and genetic properties of tumors associated with local immune cytolytic activity JO - Cell VL - 160 UR - https://doi.org/10.1016/j.cell.2014.12.033 DO - 10.1016/j.cell.2014.12.033 ID - Rooney2015 ER - TY - JOUR AU - Giraldo, N. A. AU - Becht, E. AU - Pages, F. AU - Skliris, G. AU - Verkarre, V. AU - Vano, Y. PY - 2015 DA - 2015// TI - Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2926 DO - 10.1158/1078-0432.CCR-14-2926 ID - Giraldo2015 ER - TY - JOUR AU - Geissler, K. AU - Fornara, P. AU - Lautenschläger, C. AU - Holzhausen, H. -. J. AU - Seliger, B. AU - Riemann, D. PY - 2015 DA - 2015// TI - Immune signature of tumor infiltrating immune cells in renal cancer JO - Oncoimmunology VL - 4 UR - https://doi.org/10.4161/2162402X.2014.985082 DO - 10.4161/2162402X.2014.985082 ID - Geissler2015 ER - TY - JOUR AU - Senbabaoglu, Y. AU - Gejman, R. S. AU - Winer, A. G. AU - Liu, M. AU - Allen, E. M. AU - Velasco, G. PY - 2016 DA - 2016// TI - Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures JO - Genome Biol VL - 17 UR - https://doi.org/10.1186/s13059-016-1092-z DO - 10.1186/s13059-016-1092-z ID - Senbabaoglu2016 ER - TY - JOUR AU - Peper, J. K. AU - Stevanović, S. PY - 2015 DA - 2015// TI - A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapy JO - Cancer Immunol Immunother VL - 64 UR - https://doi.org/10.1007/s00262-015-1682-8 DO - 10.1007/s00262-015-1682-8 ID - Peper2015 ER - TY - STD TI - Weinzierl AO, Lemmel C, Schoor O, Muller M, Kruger T, Wernet D, et al. Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics. 2007;6:102–13. https://doi.org/10.1074/mcp.M600310-MCP200. ID - ref94 ER - TY - STD TI - Newey A, Griffiths B, Michaux J, Pak HS, Stevenson BJ, Woolston A, et al. Immunopeptidomics of colorectal cancer organoids reveals a sparse. HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. J Immunother Cancer. 2019;7:2509. https://doi.org/10.1186/s40425-019-0769-8. ID - ref95 ER - TY - JOUR AU - Freudenmann, L. K. AU - Marcu, A. AU - Stevanović, S. PY - 2018 DA - 2018// TI - Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry JO - Immunology VL - 154 UR - https://doi.org/10.1111/imm.12936 DO - 10.1111/imm.12936 ID - Freudenmann2018 ER - TY - JOUR AU - Bassani-Sternberg, M. AU - Coukos, G. PY - 2016 DA - 2016// TI - Mass spectrometry-based antigen discovery for cancer immunotherapy JO - Curr Opin Immunol VL - 41 UR - https://doi.org/10.1016/j.coi.2016.04.005 DO - 10.1016/j.coi.2016.04.005 ID - Bassani-Sternberg2016 ER - TY - JOUR AU - Stickel, J. S. AU - Weinzierl, A. O. AU - Hillen, N. AU - Drews, O. AU - Schuler, M. M. AU - Hennenlotter, J. PY - 2009 DA - 2009// TI - HLA ligand profiles of primary renal cell carcinoma maintained in metastases JO - Cancer Immunol Immunother VL - 58 UR - https://doi.org/10.1007/s00262-008-0655-6 DO - 10.1007/s00262-008-0655-6 ID - Stickel2009 ER - TY - JOUR AU - Walter, S. AU - Weinschenk, T. AU - Stenzl, A. AU - Zdrojowy, R. AU - Pluzanska, A. AU - Szczylik, C. PY - 2012 DA - 2012// TI - Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2883 DO - 10.1038/nm.2883 ID - Walter2012 ER - TY - JOUR AU - Rini, B. I. AU - Stenzl, A. AU - Zdrojowy, R. AU - Kogan, M. AU - Shkolnik, M. AU - Oudard, S. PY - 2016 DA - 2016// TI - IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30408-9 DO - 10.1016/S1470-2045(16)30408-9 ID - Rini2016 ER - TY - JOUR AU - Powell, D. J. AU - Rosenberg, S. A. PY - 2004 DA - 2004// TI - Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination JO - J Immunother VL - 27 UR - https://doi.org/10.1097/00002371-200401000-00004 DO - 10.1097/00002371-200401000-00004 ID - Powell2004 ER - TY - JOUR AU - Klebanoff, C. A. AU - Acquavella, N. AU - Yu, Z. AU - Restifo, N. P. PY - 2011 DA - 2011// TI - Therapeutic cancer vaccines: are we there yet? JO - Immunol Rev VL - 239 UR - https://doi.org/10.1111/j.1600-065X.2010.00979.x DO - 10.1111/j.1600-065X.2010.00979.x ID - Klebanoff2011 ER - TY - JOUR AU - Kumai, T. AU - Fan, A. AU - Harabuchi, Y. AU - Celis, E. PY - 2017 DA - 2017// TI - Cancer immunotherapy: moving forward with peptide T cell vaccines JO - Curr Opin Immunol VL - 47 UR - https://doi.org/10.1016/j.coi.2017.07.003 DO - 10.1016/j.coi.2017.07.003 ID - Kumai2017 ER - TY - JOUR AU - Kannt, A. AU - Rajagopal, S. AU - Kadnur, S. V. AU - Suresh, J. AU - Bhamidipati, R. K. AU - Swaminathan, S. PY - 2018 DA - 2018// TI - A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-22081-7 DO - 10.1038/s41598-018-22081-7 ID - Kannt2018 ER - TY - JOUR AU - Babault, N. AU - Allali-Hassani, A. AU - Li, F. AU - Fan, J. AU - Yue, A. AU - Ju, K. PY - 2018 DA - 2018// TI - Discovery of bisubstrate inhibitors of nicotinamide N-methyltransferase (NNMT) JO - J Med Chem VL - 61 UR - https://doi.org/10.1021/acs.jmedchem.7b01422 DO - 10.1021/acs.jmedchem.7b01422 ID - Babault2018 ER - TY - JOUR AU - Horning, B. D. AU - Suciu, R. M. AU - Ghadiri, D. A. AU - Ulanovskaya, O. A. AU - Matthews, M. L. AU - Lum, K. M. PY - 2016 DA - 2016// TI - Chemical proteomic profiling of human methyltransferases JO - J Am Chem Soc VL - 138 UR - https://doi.org/10.1021/jacs.6b07830 DO - 10.1021/jacs.6b07830 ID - Horning2016 ER - TY - JOUR AU - Futagi, Y. AU - Kobayashi, M. AU - Narumi, K. AU - Furugen, A. AU - Iseki, K. PY - 2018 DA - 2018// TI - Identification of a selective inhibitor of human monocarboxylate transporter 4 JO - Biochem Biophys Res Commun VL - 495 UR - https://doi.org/10.1016/j.bbrc.2017.10.025 DO - 10.1016/j.bbrc.2017.10.025 ID - Futagi2018 ER - TY - JOUR AU - Rini, B. I. AU - Halabi, S. AU - Rosenberg, J. E. AU - Stadler, W. M. AU - Vaena, D. A. AU - Archer, L. PY - 2010 DA - 2010// TI - Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206 JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.5561 DO - 10.1200/JCO.2009.26.5561 ID - Rini2010 ER - TY - JOUR AU - Escudier, B. AU - Bellmunt, J. AU - Negrier, S. AU - Bajetta, E. AU - Melichar, B. AU - Bracarda, S. PY - 2010 DA - 2010// TI - Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.7849 DO - 10.1200/JCO.2009.26.7849 ID - Escudier2010 ER - TY - JOUR AU - Rivenbark, A. G. AU - Stolzenburg, S. AU - Beltran, A. S. AU - Yuan, X. AU - Rots, M. G. AU - Strahl, B. D. AU - Blancafort, P. PY - 2012 DA - 2012// TI - Epigenetic reprogramming of cancer cells via targeted DNA methylation JO - Epigenetics VL - 7 UR - https://doi.org/10.4161/epi.19507 DO - 10.4161/epi.19507 ID - Rivenbark2012 ER - TY - JOUR AU - Lei, Y. AU - Zhang, X. AU - Su, J. AU - Jeong, M. AU - Gundry, M. C. AU - Huang, Y. -. H. PY - 2017 DA - 2017// TI - Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms16026 DO - 10.1038/ncomms16026 ID - Lei2017 ER - TY - JOUR AU - Almstedt, M. AU - Blagitko-Dorfs, N. AU - Duque-Afonso, J. AU - Karbach, J. AU - Pfeifer, D. AU - Jäger, E. AU - Lübbert, M. PY - 2010 DA - 2010// TI - The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells JO - Leuk Res VL - 34 UR - https://doi.org/10.1016/j.leukres.2010.02.004 DO - 10.1016/j.leukres.2010.02.004 ID - Almstedt2010 ER - TY - STD TI - Shraibman B, Kadosh DM, Barnea E, Admon A. Human leukocyte antigen (HLA) peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy. Mol Cell Proteomics. 2016;15:3058–70. https://doi.org/10.1074/mcp.M116.060350. ID - ref113 ER - TY - JOUR AU - Ott, P. A. AU - Hu, Z. AU - Keskin, D. B. AU - Shukla, S. A. AU - Sun, J. AU - Bozym, D. J. PY - 2017 DA - 2017// TI - An immunogenic personal neoantigen vaccine for patients with melanoma JO - Nature VL - 547 UR - https://doi.org/10.1038/nature22991 DO - 10.1038/nature22991 ID - Ott2017 ER - TY - JOUR AU - Hilf, N. AU - Kuttruff-Coqui, S. AU - Frenzel, K. AU - Bukur, V. AU - Stevanović, S. AU - Gouttefangeas, C. PY - 2019 DA - 2019// TI - Actively personalized vaccination trial for newly diagnosed glioblastoma JO - Nature VL - 565 UR - https://doi.org/10.1038/s41586-018-0810-y DO - 10.1038/s41586-018-0810-y ID - Hilf2019 ER - TY - JOUR AU - Keskin, D. B. AU - Anandappa, A. J. AU - Sun, J. AU - Tirosh, I. AU - Mathewson, N. D. AU - Li, S. PY - 2019 DA - 2019// TI - Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial JO - Nature VL - 565 UR - https://doi.org/10.1038/s41586-018-0792-9 DO - 10.1038/s41586-018-0792-9 ID - Keskin2019 ER - TY - JOUR AU - Vitiello, A. AU - Zanetti, M. PY - 2017 DA - 2017// TI - Neoantigen prediction and the need for validation JO - Nat Biotechnol VL - 35 UR - https://doi.org/10.1038/nbt.3932 DO - 10.1038/nbt.3932 ID - Vitiello2017 ER - TY - JOUR AU - Backert, L. AU - Kohlbacher, O. PY - 2015 DA - 2015// TI - Immunoinformatics and epitope prediction in the age of genomic medicine JO - Genome Med VL - 7 UR - https://doi.org/10.1186/s13073-015-0245-0 DO - 10.1186/s13073-015-0245-0 ID - Backert2015 ER - TY - JOUR AU - Gerlinger, M. AU - Horswell, S. AU - Larkin, J. AU - Rowan, A. J. AU - Salm, M. P. AU - Varela, I. PY - 2014 DA - 2014// TI - Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing JO - Nat Genet VL - 46 UR - https://doi.org/10.1038/ng.2891 DO - 10.1038/ng.2891 ID - Gerlinger2014 ER - TY - JOUR AU - Turajlic, S. AU - Xu, H. AU - Litchfield, K. AU - Rowan, A. AU - Chambers, T. AU - Lopez, J. I. PY - 2018 DA - 2018// TI - Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal JO - Cell VL - 173 UR - https://doi.org/10.1016/j.cell.2018.03.057 DO - 10.1016/j.cell.2018.03.057 ID - Turajlic2018 ER - TY - JOUR AU - Mitchell, T. J. AU - Turajlic, S. AU - Rowan, A. AU - Nicol, D. AU - Farmery, J. H. R. AU - O’Brien, T. PY - 2018 DA - 2018// TI - Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal JO - Cell VL - 173 UR - https://doi.org/10.1016/j.cell.2018.02.020 DO - 10.1016/j.cell.2018.02.020 ID - Mitchell2018 ER - TY - JOUR AU - Klatt, M. G. AU - Kowalewski, D. J. AU - Schuster, H. AU - Marco, M. AU - Hennenlotter, J. AU - Stenzl, A. PY - 2016 DA - 2016// TI - Carcinogenesis of renal cell carcinoma reflected in HLA ligands: a novel approach for synergistic peptide vaccination design JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1204504 DO - 10.1080/2162402X.2016.1204504 ID - Klatt2016 ER - TY - JOUR AU - Miikkulainen, P. AU - Hogel, H. AU - Rantanen, K. AU - Suomi, T. AU - Kouvonen, P. AU - Elo, L. L. AU - Jaakkola, P. M. PY - 2017 DA - 2017// TI - HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma JO - Cancer Metab VL - 5 UR - https://doi.org/10.1186/s40170-017-0167-y DO - 10.1186/s40170-017-0167-y ID - Miikkulainen2017 ER - TY - JOUR AU - Xie, L. AU - Pi, X. AU - Mishra, A. AU - Fong, G. AU - Peng, J. AU - Patterson, C. PY - 2012 DA - 2012// TI - PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI62374 DO - 10.1172/JCI62374 ID - Xie2012 ER - TY - JOUR AU - Tennant, D. A. AU - Gottlieb, E. PY - 2010 DA - 2010// TI - HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression JO - J Mol Med VL - 88 UR - https://doi.org/10.1007/s00109-010-0627-0 DO - 10.1007/s00109-010-0627-0 ID - Tennant2010 ER - TY - JOUR AU - Mao, K. AU - You, C. AU - Lei, D. AU - Zhang, H. PY - 2017 DA - 2017// TI - Potential regulation of glioma through the induction of apoptosis signaling via Egl-9 family hypoxia-inducible factor 3 JO - Oncol Lett VL - 13 UR - https://doi.org/10.3892/ol.2016.5492 DO - 10.3892/ol.2016.5492 ID - Mao2017 ER - TY - JOUR AU - Högel, H. AU - Miikkulainen, P. AU - Bino, L. AU - Jaakkola, P. M. PY - 2015 DA - 2015// TI - Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27 JO - Mol Cancer VL - 14 UR - https://doi.org/10.1186/s12943-015-0410-5 DO - 10.1186/s12943-015-0410-5 ID - Högel2015 ER - TY - JOUR AU - Högel, H. AU - Rantanen, K. AU - Jokilehto, T. AU - Grenman, R. AU - Jaakkola, P. M. PY - 2011 DA - 2011// TI - Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0027112 DO - 10.1371/journal.pone.0027112 ID - Högel2011 ER - TY - JOUR AU - German, N. J. AU - Yoon, H. AU - Yusuf, R. Z. AU - Murphy, J. P. AU - Finley, L. W. AU - Laurent, G. PY - 2016 DA - 2016// TI - PHD3 loss in cancer enables metabolic reliance on fatty acid oxidation via deactivation of ACC2 JO - Mol Cell VL - 63 UR - https://doi.org/10.1016/j.molcel.2016.08.014 DO - 10.1016/j.molcel.2016.08.014 ID - German2016 ER - TY - JOUR AU - Chen, N. AU - Rinner, O. AU - Czernik, D. AU - Nytko, K. J. AU - Zheng, D. AU - Stiehl, D. P. PY - 2011 DA - 2011// TI - The oxygen sensor PHD3 limits glycolysis under hypoxia via direct binding to pyruvate kinase JO - Cell Res VL - 21 UR - https://doi.org/10.1038/cr.2011.66 DO - 10.1038/cr.2011.66 ID - Chen2011 ER - TY - JOUR AU - Luo, W. AU - Hu, H. AU - Chang, R. AU - Zhong, J. AU - Knabel, M. AU - O’Meally, R. PY - 2011 DA - 2011// TI - Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 JO - Cell VL - 145 UR - https://doi.org/10.1016/j.cell.2011.03.054 DO - 10.1016/j.cell.2011.03.054 ID - Luo2011 ER - TY - STD TI - European Genome-phenome Archive (EGA). Study of primary renal cancers as well as metastases derived from renal cancers in various distant organs. Study Identifier: EGAS00001001176. https://www.ebi.ac.uk/ega/studies/EGAS00001001176. UR - https://www.ebi.ac.uk/ega/studies/EGAS00001001176 ID - ref132 ER - TY - JOUR AU - Perez-Riverol, Y. AU - Csordas, A. AU - Bai, J. AU - Bernal-Llinares, M. AU - Hewapathirana, S. AU - Kundu, D. J. PY - 2019 DA - 2019// TI - The PRIDE database and related tools and resources in 2019: improving support for quantification data JO - Nucleic Acids Res VL - 47 UR - https://doi.org/10.1093/nar/gky1106 DO - 10.1093/nar/gky1106 ID - Perez-Riverol2019 ER - TY - STD TI - PRIDE Archive. Data set Identifier: PXD017149. https://www.ebi.ac.uk/pride/. UR - https://www.ebi.ac.uk/pride/ ID - ref134 ER -